Cmpx stock forecast.

BOSTON, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in the following investor events during the month of September 2023.

Cmpx stock forecast. Things To Know About Cmpx stock forecast.

NSD:CMPX Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes Leader in personal finance news and business forecasting. Get trusted advice on investing, retirement, taxes, saving, real estate, cars, college, insurance.BHC Stock 12 Months Forecast. $9.00. (30.72% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Bausch Health Companies in the last 3 months. The average price target is $9.00 with a high forecast of $16.00 and a low forecast of $6.00. The average price target represents a 30.72% change from the last price of $6.89.66.07%. Get the latest Compass Therapeutics Inc. (CMPX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...

Track Compass Therapeutics Inc (CMPX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsWall Street Stock Market & Finance report, prediction for the future: You'll find the Compx International, Inc. - Class A share forecasts, stock quote and buy / sell signals below. According to present data Compx International, Inc. - Class A's CIX shares and potentially its market environment have been in a bullish cycle in the last 12 months ...Meta Materials, Inc. engages in the manufacture and development of functional materials. Its technology platform enables global brands to deliver products to customers in consumer electronics, 5G ...

Based on short-term price targets offered by seven analysts, the average price target for Compass Therapeutics, Inc. comes to $9.33. The forecasts range from a low of $8.00 to a high of $11.00 ...

CMPX Stock 12 Months Forecast. $10.50. (510.47% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Compass Therapeutics in the last 3 months. The average price target is $10.50 with a high forecast of $11.00 and a low forecast of $10.00. The average price target represents a 510.47% change from the last price of $1.72.Iterum Therapeutics plc. Analyst Report: Pfizer Inc. Pfizer is a leading developer and manufacturer of pharmaceuticals and biotech drugs. Its products include oncology and immunology drugs ...CMPX Stock predictions, price target today, Technical and Fundamental analysis to buy the best Stock$10.50 (510.47% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Compass Therapeutics in the last 3 months. The average price target is $10.50 with a …Compass Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CMPX updated stock price target summary.

FORECASTS Analyst Sentiment Leaderboard

FORECASTS Analyst Sentiment Leaderboard

Compass Therapeutics Inc. (CMPX) stock is trading at $3.95 as of 12:48 PM on Tuesday, Jan 31, an increase of $0.10, or 2.6% from the previous closing price of $3.85. The stock has traded between $3.88 and $4.13 so far today. Volume today is less active than usual.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.In many cases to predict stock price, gold and crude oil have been used as extra indicators [36], in some of the works, 43 technical indicators as input features along with LSTM to forecast price ...Find the latest Fusion Pharmaceuticals Inc. (FUSN) stock quote, history, news and other vital information to help you with your stock trading and investing.The average Compass Therapeutics stock price prediction forecasts a potential upside of 528.93% from the current CMPX share price of $1.59. What is CMPX's forecast return on assets (ROA) for 2023-2026?Compass Therapeutics Inc. (CMPX) stock is trading at $3.95 as of 12:48 PM on Tuesday, Jan 31, an increase of $0.10, or 2.6% from the previous closing price of $3.85. The stock has traded between $3.88 and $4.13 so far today. Volume today is less active than usual.Their COEP share price targets range from $3.00 to $6.00. On average, they expect the company's stock price to reach $4.33 in the next twelve months. This suggests a possible upside of 270.4% from the stock's current price. View analysts price targets for COEP or view top-rated stocks among Wall Street analysts.

Compound Price Live Data. The live Compound price today is $51.45 USD with a 24-hour trading volume of $77,211,369 USD. We update our COMP to USD price in real-time. Compound is up 1.11% in the last 24 hours. The current CoinMarketCap ranking is #107, with a live market cap of $412,787,173 USD. It has a circulating supply of 8,023,528 …Compass Therapeutics, Inc. (CMPX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 1.6500 -0.0700 (-4.07%) At close: 04:00PM EST 1.6500 0.00 (0.00%) After hours: 04:20PM EST...Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.18 brokerages have issued 1-year price objectives for ChargePoint's shares. Their CHPT share price targets range from $2.00 to $17.00. On average, they expect the company's share price to reach $9.13 in the next year. This suggests a possible upside of 380.1% from the stock's current price.Get actionable alerts from top Wall Street Analysts. Find out before anyone else which stock is going to shoot up. Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. Get the latest Apexigen APGN Stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com.Back to CMPX Overview. *The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once ...

... Cmpx 2022, House of the rising sun shrewsbury, Predator alien face, Eye ... share price, Byo wedding venues philadelphia, Veterinary care near me, Tony ...

SOS Limited - ADR Stock Forecast, SOS stock price prediction. Price target in 14 days: 4.203 USD. The best long-term & short-term SOS Limited - ADR share price ...Webull provides a variety of real-time CMPX stock news. You can receive the latest news about Compass Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions. About CMPX. Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company is focused on …Analyst Forecast. According to 4 analysts, the average rating for CMPX stock is "Strong Buy." The 12-month stock price forecast is $9.33, which is an increase …Get actionable alerts from top Wall Street Analysts. Find out before anyone else which stock is going to shoot up. Get powerful stock screeners & detailed portfolio analysis. Subscribe Now See Plans & Pricing. Get the latest Apexigen APGN Stock forecast and financial predictions, including earnings and sales forecast, on TipRanks.com.Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs. Register for your free account today at data ...The CompX International stock forecast for tomorrow is $ 23.75, which would represent a -1.06% loss compared to the current price. In the next week, the price of CIX is expected to decrease by -9.90% and hit $ 21.62. As far as the long-term CompX International stock forecast is concerned, here ... To get a sense of who is truly in control of Compass Therapeutics, Inc. (NASDAQ:CMPX), it is important to understand the ownership structure of the business. The group holding the most number of ...

According to the issued ratings of 6 analysts in the last year, the consensus rating for Mesoblast stock is Hold based on the current 1 sell rating, 3 hold ratings and 2 buy ratings for MESO. The average twelve-month price prediction for Mesoblast is $7.13 with a high price target of $17.00 and a low price target of $1.50.

Predictions of CMPX stock price for tomorrow.

Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Analyst Forecast. According to 4 analysts, the average rating for CMPX stock is "Strong Buy." The 12-month stock price forecast is $9.33, which is an increase of 452.07% from the latest price.Stock Price Forecast. According to 4 stock analysts, the average 12-month stock price forecast for CMPX stock stock is $9.33, which predicts an increase of 442.44%. The lowest target is $8.00 and the highest is $10.3. On average, analysts rate CMPX stock stock as a strong buy.The average TRACON Pharmaceuticals stock prediction of $12.40 implies an upside potential of 392.1% to current levels for this stock.Compass Therapeutics (NASDAQ: CMPX)Compass Therapeutics ...Compass Therapeutics, Inc. - Hold. Zacks' proprietary data indicates that Compass Therapeutics, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the CMPX shares ...Complete Compass Therapeutics Inc. stock information by Barron's. View real-time CMPX stock price and news, along with industry-best analysis.Find real-time CIX - CompX International Inc stock quotes, company profile, news and forecasts from CNN Business. After a massive correction of 61% YTD, CMPX stock looks deeply undervalued and is poised for a strong reversal rally. As an overview, Compass is a clinical-stage oncology-focused company that’s ...

Our goal is to do fundamental research, invent new technology, and create frameworks for stock forecast.Their COEP share price targets range from $3.00 to $6.00. On average, they expect the company's stock price to reach $4.33 in the next twelve months. This suggests a possible upside of 270.4% from the stock's current price. View analysts price targets for COEP or view top-rated stocks among Wall Street analysts.Typically, the average forecast for the group predicts the S&P 500 climbing by about 10%, which is in line with historical averages. 14h ago The Wall Street JournalInstagram:https://instagram. 1964 silver kennedy half dollar wortha i companies to invest insites like webullxlk fund Get free stock tools, free stock ratings, free stock charts and calculate the value of stocks to buy opera singer bocelliishares us real estate etf According to the issued ratings of 4 analysts in the last year, the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX. The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00. best stocks to invest in right now on cash app SOS Limited - ADR Stock Forecast, SOS stock price prediction. Price target in 14 days: 4.203 USD. The best long-term & short-term SOS Limited - ADR share price ... APRE Stock 12 Months Forecast. $15.00. (300.00% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Aprea Therapeutics in the last 3 months. The average price target is $15.00 with a high forecast of $20.00 and a low forecast of $9.00. The average price target represents a 300.00% change from the last price of $3.75.